Bo Hu

Bo Hu works in early discovery at Bristol Myers Squibb, where he focuses on the computational aspects of drug development in hematology oncology. His work spans the critical pre-clinical phase before drugs enter clinical trials, including target selection and evaluation, candidate molecule testing, and model assessment. Bo specializes in model selection, molecular data analysis, and experimental design to ensure optimal data collection. His computational expertise supports the discovery pipeline by helping select appropriate models and analyze complex molecular data, contributing to BMS’s efforts in developing novel therapies for blood cancers and hematologic disorders.